Virtual Care

Dr. Omar Manejwala, chief medical officer at DarioHealth, discusses the company's experience with self-insured employers bending costs by employing digital therapeutics while simultaneously supporting individuals with chronic conditions.

Felix Lee, head of organizational capability and transformation at Sanofi, relays how the pharma company leverages DarioHealth's digital therapeutics to complement its drug offerings and gather a comprehensive picture of a patient's health.

Amos Adler, founder, and president at Memotext, discusses his company's flagship digital app for the schizophrenia and psychosis population and how its portal helps caregivers engage with patients and identify the risks for relapse and readmission.

Michael Pace, founder and president of PalmHealthCo, discusses how his international consulting company helps organizations improve commercialization and market access for technology solutions and his experience with Pear Therapeutics.

Rachael Charbonneau, senior program development manager of health science at the American Heart Association, discusses how the organization's professional training programs help improve healthcare professionals' digital literacy.

Meg Barron, Peterson Health Technology Institute's managing director of engagement and outreach, relays how the organization independently evaluates digital health offerings' clinical efficacy, budget impact, and return on investment.

DuploCloud account executives Joshua Mattson and Aaron Blackmon discuss building IT platforms within digital therapeutics platforms and health tech companies with compliance and security in mind.

Alberta Spreafico, senior vice president of health innovation at Eversana, explains how the company, along with the Digital Therapeutics Alliance, analyzes, maps and reports on reimbursement frameworks in Europe for digital therapeutics.

Vijay Ravindran, CEO of Floreo, discusses how virtual reality is particularly beneficial for teaching individuals with neurodiverse issues social and life skills and how investment in extended reality-based digital therapeutics has evolved.

Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses what a digital therapeutic is exactly, why the organization held its recent summit in D.C. and how the company works with Congress on legislation around reimbursement.

The U.S. health system is not a system but a convoluted array of institutions, says Hannes Klöpper, HelloBetter cofounder and CEO. Using digital therapeutics is one way to lower barriers to care and improve cost efficiency and access.

Scott Stuewe, president and CEO of DirectTrust, and Andy Molnar, CEO of the Digital Therapeutics Alliance, highlight the partners' efforts to move digital therapeutics forward by ensuring validation and accreditation in healthcare.